Page last updated: 2024-08-23

etoposide and Ventricular Dysfunction

etoposide has been researched along with Ventricular Dysfunction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bernstein, ML; Devidas, M; Gebhardt, MC; Goorin, AM; Grier, HE; Healey, JH; Krailo, MD; Lipshultz, SE; Meyers, PA; Sato, JK; Schwartz, CL; Steinherz, LJ; Teot, LA; Wexler, LH	1

Other Studies

1 other study(ies) available for etoposide and Ventricular Dysfunction

Article	Year
Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group. Pediatric blood & cancer, 2016, Volume: 63, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cardiotonic Agents; Child; Child, Preschool; Cisplatin; Dexrazoxane; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Methotrexate; Osteosarcoma; Treatment Outcome; Ventricular Dysfunction	2016

Article

Year

Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group.

Pediatric blood & cancer, 2016, Volume: 63, Issue:1

Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cardiotonic Agents; Child; Child, Preschool; Cisplatin; Dexrazoxane; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Methotrexate; Osteosarcoma; Treatment Outcome; Ventricular Dysfunction

2016